Biotech IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers July 27, 2026
Biotech Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company July 27, 2026
Biotech argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline July 27, 2026
Biotech Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28 July 25, 2026
Biotech Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm July 23, 2026
Biotech argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update July 23, 2026
Search
Biotech
July 27, 2026
July 27, 2026
July 27, 2026
July 27, 2026
July 25, 2026
July 25, 2026
July 24, 2026
July 24, 2026
July 23, 2026
July 23, 2026
